Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management
Review published in Chest (2009)
Abstract
Thrombocytopenia following heparin administration can be associated with an immune reaction, now referred to as heparin-induced thrombocytopenia (HIT). HIT is essentially a prothrombotic disorder mediated by an IgG antiplatelet factor 4/heparin antibody, which induces platelet, endothelial cell, monocyte, and other cellular activation, leading to thrombin generation and thrombotic complications. Indeed, HIT can also be regarded as a serious adverse drug effect. Importantly, HIT can be a life-threatening and limb-threatening condition frequently associated with characteristically severe and extensive thromboembolism (both venous and arterial) rather than with bleeding. This article provides an overview of HIT, with an emphasis on the clinical diagnosis and management.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
Contemporary clinical review of HIT pathophysiology (anti-PF4/heparin IgG, platelet activation, thrombin generation) and management algorithms incorporating direct thrombin inhibitors lepirudin and argatroban.
Why This Matters for Hirudotherapy
This review provides an overview of heparin-induced thrombocytopenia (HIT), a prothrombotic immune-mediated adverse drug reaction mediated by IgG antiplatelet factor 4/heparin antibodies, with emphasis on clinical diagnosis and management. The abstract describes HIT's pathogenesis, association with severe venous and arterial thromboembolism, and its character as a life- and limb-threatening condition. The article has no direct relevance to ASH's domain: the abstract does not mention hirudin, lepirudin, leeches, leech-derived therapy, or the leech secretome, and contains no discussion of hirudotherapy. CAVEAT: This is a review article offering a clinical overview; the abstract provides no content on leech-derived agents or related therapies, making its relevance to ASH's core domain negligible.
Citation
Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
Shantsila E et al. · Chest, 2009
Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026